This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Is Erie Indemnity (ERIE) a Solid Growth Stock? 3 Reasons to Think " Yes "
by Zacks Equity Research
Erie Indemnity (ERIE) possesses solid growth attributes, which could help it handily outperform the market.
3 Reasons Why Erie Indemnity (ERIE) Is a Great Growth Stock
by Zacks Equity Research
Erie Indemnity (ERIE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Erie Indemnity (ERIE) Q3 Earnings Beat Estimates
by Zacks Equity Research
Erie Indemnity (ERIE) delivered earnings and revenue surprises of 7.14% and -0.15%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Erie Indemnity (ERIE) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Erie Indemnity (ERIE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Erie Indemnity (ERIE) Q2 Earnings Beat Estimates
by Zacks Equity Research
Erie Indemnity (ERIE) delivered earnings and revenue surprises of 2.44% and -0.57%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Erie Indemnity (ERIE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Erie Indemnity (ERIE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Aon to Offer Micro Insurance in Sri Lanka Via Blockchain
by Zacks Equity Research
Aon (AON) collaborates with Oxfam and Etherisc to provide Sri Lankan farmers with accessibility to a blockchain platform.
Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for FNY
Arthur J. Gallagher to Buy Minority Stake in Renomia a.s
by Zacks Equity Research
Arthur J. Gallagher's (AJG) intended acquisition of a minority stake in Renomia a.s. is in tandem with its strategy to expand internationally.
eHealth Surges 114% Year to Date: Will the Rally Continue?
by Zacks Equity Research
eHealth's (EHTH) operational excellence and growth initiatives help the stock continue the bull run.
Willis Towers Set to Grow on Rising Commissions and Fees
by Zacks Equity Research
Willis Towers (WLTW) remains well poised on organic growth in commissions and fees, solid customer retention, growing new business and improving liquidity, though high costs concern.
Why Should You Hold Aon (AON) in Your Portfolio Right Now?
by Zacks Equity Research
Riding high on the rising top line and growth strategies, Aon (AON) holds immense potential to reap benefits for investors.
Aon Ties Up With CoverWallet to Establish Presence in Australia
by Zacks Equity Research
With this tie-up, Aon (AON) gets an access to the evolving small and medium enterprise (SME) digital insurance market segment worth $100 billion.
Why Should You Hold Marsh & McLennan in Your Portfolio?
by Zacks Equity Research
Riding high on a steady top line, sturdy financial position and inorganic growth, Marsh & McLennan (MMC) has high potential to reap benefits for investors.
Marsh & McLennan Unit Launches Cloud-Based Tech Solution
by Zacks Equity Research
Marsh & McLennan (MMC) arm Mercer introduces Mercer Mobility Management Platform in partnership with ServiceNow.
Willis Towers (WLTW) Ups Dividend by 13%, Okays Buyback
by Zacks Equity Research
Willis Towers' (WLTW) efforts to raise dividend by 13% and add $400 million to share buyback program vouch for its operational strength in support of effective capital deployment.
Brown & Brown to Become Affordable, Stock Split for 2-for-1
by Zacks Equity Research
Brown & Brown's (BRO) decision to split stock for 2-for-1 might make it an attractive pick for potential investors
Erie Indemnity Boosts Shareholders' Value With Dividend Hike
by Zacks Equity Research
Erie Indemnity's (ERIE) 7.3% hike in quarterly dividend vouches for the company's generation of solid cash, driven by a stable operational efficiency.
New Strong Sell Stocks for August 30th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Zacks Industry Outlook Highlights: SPDR S&P Insurance ETF, Health Insurance Innovations, Erie Indemnity, Legal & General Group and Argo Group International Holdings
by Zacks Equity Research
Zacks Industry Outlook Highlights: SPDR S&P Insurance ETF, Health Insurance Innovations, Erie Indemnity, Legal & General Group and Argo Group International Holdings
U.S. Insurance Stock Outlook - April 2017
by Kalyan Nandy
The gradual improvement in the interest rate environment after almost a decade has surprisingly failed to attract investors' attention to insurance stocks.
Top Ranked Income Stocks to Buy for April 18th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, April 18th:
Marsh & McLennan Adds RJF Financial to Business Portfolio
by Zacks Equity Research
Marsh & McLennan Companies, Inc. (MMC) unit has acquired RJF Financial Services, a retirement advisory firm based in Brooklyn Park, MN.
Validus Holdings (VR) and its Units Receive Rating Action
by Zacks Equity Research
Validus Reinsurance, Ltd., an affiliate of Validus Holdings, Ltd. (VR), recently received rating action from credit rating giant A.M. Best.
Zacks.com featured highlights: Marcus, Papa Murphy's Holdings, Erie Indemnity, Arbor Realty Trust and Farmland Partners
by Zacks Equity Research
Zacks.com featured highlights: Marcus, Papa Murphy's Holdings, Erie Indemnity, Arbor Realty Trust and Farmland Partners